Table 2.

Hypofractionated Radiotherapy for bladder cancer

Study	Patients (n)	Stage	Treament (Gy)	Outcome
McLaren et al. (1997)	65	T2-T4	30 Gy/5F (n = 53)	OS 9 months
			36 Gy/6F (n = 12)
Turgeon et al. (2008)	24	T2-T3	50 Gy/20F	3-year OS 61%
				3-year DSS 71%
Kouloulias et al. (2013)	58	T1-T2	36 Gy/6F	PFS 14 months
Fosså et al. (1991)	39	T4	30 Gy/10F	OS 7.5 months
Salminen et al. (1992)	94	T1-T4	30 Gy/6F	DSS 13.3 months
				5-year OS 13%

OS = overall survival, DSS = disease-specific survival, PFS = progression-free survival.